FDA considers Avastin as first-line ovarian cancer therapy

27th October 2017 Uncategorised 0

US regulators are reviewing a potential new indication for Avastin as a first-line option for advanced ovarian cancer, filed by Roche group Genentech.

More: FDA considers Avastin as first-line ovarian cancer therapy
Source: News